Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy
miR-122 的缺失会促进接受新辅助化疗的三阴性乳腺癌患者的细胞迁移并导致预后不良。
期刊:Clinical & Translational Oncology
影响因子:2.5
doi:10.1007/s12094-025-04082-x
Flores-Fortis, Mauricio; Perez-Añorve, Isidro X; Patiño-Morales, Carlos C; Soto-Reyes, Ernesto; Gonzalez-De la Rosa, Claudia H; Manzo-Merino, Joaquin; Aguilar-Rojas, Arturo; Villegas, Nicolas; Arechaga-Ocampo, Elena